세계의 의료 시뮬레이션 시장 보고서 : 제품 및 서비스, 충실도, 최종사용자, 지역별(2024-2032년)

The global medical simulation market size reached US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 11.8% during 2024-2032.

Medical simulation refers to the virtual duplication of in-situ activities for training, feedback and experiential learning. It is commonly used by physicians, nurses, surgeons and other practitioners under training to learn, practice and assess their skills in a safe environment. Medical simulation uses body manikins, task trainers and virtual reality (VR)-based systems for laparoscopic, gynecological, cardiovascular, arthroscopic, spinal, endovascular, dental and eye simulation. It provides feedback from observers, such as professors, peers, actor-patients and video cameras, and aids in enhancing patient safety, optimizing communications and improving crisis resource management. As a result, it finds extensive applications across hospitals, academic institutes, military organizations, research facilities and ambulatory care centers.

Medical Simulation Market Trends:

Significant growth in the medical industry across the globe is among the key factors creating a positive outlook for the market. Moreover, the increasing awareness regarding the benefits of simulation-based learning among the masses is providing a thrust to the market growth. In line with this, the widespread adoption of laparoscopic simulation systems for effective cancer treatment is also contributing to the market growth. Various technological advancements, such as the integration of augmented reality (AR), robotics and artificial intelligence (AI) solutions in interventional simulators, are acting as other growth-inducing factors. These simulators are extensively used for training physicians in conducting cholecystectomy, appendectomy, gastric bypass, tubal ligation and hysterectomy. Other factors, including the rising concerns regarding patient safety, along with rapid digitization of the healthcare industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and services, fidelity and end user.

Breakup by Product and Services:

Model-based Simulation

Surgical Simulation

Ultrasound Simulation

Web-based Simulation

Simulation Training Services

Breakup by Fidelity:

Low Fidelity

Medium Fidelity

High Fidelity

Breakup by End User:

Hospitals and Clinics

Academic Institutions and Research Centers

Military Organizations

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cardionics Inc. (3B Scientific GmbH), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Mentice, Operative Experience Inc., Simbionix USA Corporation (3D Systems), Simulab Corporation, Surgical Science Sweden AB, Synaptive Medical Inc., SynBone AG and VirtaMed AG.

Key Questions Answered in This Report:

• How has the global medical simulation market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global medical simulation market?
• What are the key regional markets?
• What is the breakup of the market based on the product and services?
• What is the breakup of the market based on the fidelity?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global medical simulation market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Simulation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product and Services

• 6.1 Model-based Simulation
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Surgical Simulation
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Ultrasound Simulation
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Web-based Simulation
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Simulation Training Services
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Fidelity

• 7.1 Low Fidelity
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Medium Fidelity
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 High Fidelity
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Academic Institutions and Research Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Military Organizations
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Cardionics Inc. (3B Scientific GmbH)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Gaumard Scientific Company Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Kyoto Kagaku Co. Ltd
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Laerdal Medical
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Mentice
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 Operative Experience Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Simbionix USA Corporation (3D Systems)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Simulab Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Surgical Science Sweden AB
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Synaptive Medical Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 SynBone AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 VirtaMed AG
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio